Scrub typhus showdown: which antibiotic works best when resistance is rising?
NCT ID NCT03083197
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests three antibiotic regimens for scrub typhus, a bacterial infection spread by mites. Researchers compare 7 days of doxycycline, 3 days of doxycycline, and 3 days of azithromycin in 177 hospitalized patients aged 15 and older. The goal is to see which treatment clears fever fastest and prevents relapse, especially in areas where drug resistance is a concern.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
doxycycline and azithromycin
What this could lead to
If successful, this could identify the most effective antibiotic regimen for scrub typhus, potentially reducing treatment failures and relapse in regions with drug resistance.
What could go wrong
This is a relatively small Phase 4 trial (177 participants) in specific regions, so results may not apply everywhere. Antibiotic resistance patterns vary, and the open-label design could introduce bias.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCRUB TYPHUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiangrai Prachanukroh Hospital
Chiang Rai, Thailand
-
Mae Chan District Hospital
Chiang Rai, Thailand
-
Mae Fah Luang District Hospital
Chiang Rai, Thailand
-
Mae Suai District Hospital
Chiang Rai, Thailand
-
Shoklo-Malaria Research Unit (SMRU)
Mae Sot, Changwat Tak, Thailand